Carregant...

The effect of glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial [ISRCTN54513166]

BACKGROUND: Pharmacological treatment for osteoarthritis (OA) can be divided into two groups: symptom-modifying drugs and disease-modifying drugs. Symptom-modifying drugs are currently the prescription of choice for patients with OA, as disease-modifying drugs are not yet available in usual care. Ho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rozendaal, Rianne M, Koes, Bart W, Weinans, Harrie, Uitterlinden, Elian J, van Osch, Gerjo JVM, Ginai, Abida Z, Verhaar, Jan AN, Bierma-Zeinstra, Sita MA
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1090586/
https://ncbi.nlm.nih.gov/pubmed/15850497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-6-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!